28 January 2021

Spontaneous intracerebral hematomas (ICH) are the most deadly form of stroke. Treatment options include admission to a specialized stroke unit and treatment of hypertension in the acute stage. However, both of these options have exhibited limited effectiveness. The RICH biobank collects biomaterial (DNA, plasma, serum and PAXgene) from patients with spontaneous ICH at different times in the first week after the bleeding, in order to:

1) gain insight into the role of inflammation in the development of secondary brain damage;

2) be able to explore different anti-inflammatory drugs in an ex vivo model for potential effectiveness, determined by the macrophage cytokine production capacity;

3) evaluate the effect of anti-inflammatory drug treatment in a phase II trial on markers of systemic inflammation;

4) to evaluate the effect of minimally invasive neurosurgical defecation of ICH versus regular treatment in a phase III trial on markers of systemic inflammation.

  • Want to know more about these subjects? Click on the buttons below for more news.

    Radboud Biobank

Related news items


Animation Radboud Biobank for patients

28 January 2021

The Radboud Biobank has had an animation made to inform Radboudumc visitors about the Radboud Biobank and its purpose.

read more

Framework for standards and assessment of accessing identifiable patient data for medical scientific research

28 January 2021

A Framework for standards and assessment of accessing identifiable patient data for medical scientific research has been developed in the Radboudumc.

read more

HEALTH-RI Biobank Community

28 January 2021

Biobanks are an indispensable part of the infrastructure for health research. That is why BBMRI.nl, Parelsnoer and Health-RI are joining forces.

read more

SHM sub-biobank

28 January 2021

Stichting HIV Monitoring’s (SHM) mission is to increase knowledge and understanding of all relevant aspects of HIV infection.

read more

REGenG sub-biobank

28 January 2021

The Radboud Expertise Center Sex & Gender (REG & G) is responsible for patient care, education, and research regarding gender incongruity / dysphoria.

read more